Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Nihtinen, A
Volin, L
Juvonen, E
Ruutu, T
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
    Blau, I. W.
    Schmidt-Hieber, Martin
    Leschinger, N.
    Goeldner, H.
    Knauf, W.
    Hopfenmueller, W.
    Thiel, E.
    Blau, O.
    ANNALS OF HEMATOLOGY, 2007, 86 (08) : 583 - 589
  • [2] Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
    I. W. Blau
    Martin Schmidt-Hieber
    N. Leschinger
    H. Göldner
    W. Knauf
    W. Hopfenmüller
    E. Thiel
    O. Blau
    Annals of Hematology, 2007, 86 : 583 - 589
  • [3] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [4] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Sobecks, R. M.
    Dean, R.
    Rybicki, L. A.
    Chan, J.
    Theil, K. S.
    Macklis, R.
    Andresen, S.
    Kalaycio, M.
    Pohlman, B.
    Ferraro, C.
    Cherni, K.
    Sweetenham, J.
    Copelan, E.
    Bolwell, B. J.
    BONE MARROW TRANSPLANTATION, 2008, 42 (11) : 715 - 722
  • [5] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    R M Sobecks
    R Dean
    L A Rybicki
    J Chan
    K S Theil
    R Macklis
    S Andresen
    M Kalaycio
    B Pohlman
    C Ferraro
    K Cherni
    J Sweetenham
    E Copelan
    B J Bolwell
    Bone Marrow Transplantation, 2008, 42 : 715 - 722
  • [6] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [7] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [8] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [9] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    Yerushalmi, R.
    Shem-Tov, N.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shinnoni, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1526 - 1535
  • [10] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    R Yerushalmi
    N Shem-Tov
    I Danylesko
    A Avigdor
    A Nagler
    A Shimoni
    Bone Marrow Transplantation, 2015, 50 : 1526 - 1535
12345